Margherita Digaetano

Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by<i>Klebsiella pneumoniae</i>Carbapenemase–producing<i>K. pneumoniae</i>

Mario Tumbarello, Enrico Maria Trecarichi, Alberto Corona et al. · Clinical Infectious Diseases · 2018 · 353 citations · Full text

Pharmacy, Infectious Diseases, Microbiology +17

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

François-Xavier Lescure, Hitoshi Honda, Robert Fowler et al. · The Lancet Respiratory Medicine · 2021 · 248 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience

Matteo Bassetti, Nadia Castaldo, Anna Maria Cattelan et al. · International Journal of Antimicrobial Agents · 2018 · 161 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +8

Epidemiology and Risk Factors Associated With Mortality in Consecutive Patients With Bacterial Bloodstream Infection: Impact of MDR and XDR Bacteria

Antonella Santoro, Erica Franceschini, Marianna Meschiari et al. · Open Forum Infectious Diseases · 2020 · 90 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +12

Lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients

Franco Maggiolo, Roberto Gulminetti, Layla Pagnucco et al. · BMC Infectious Diseases · 2017 · 89 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17